한빛사
>
한빛사논문
한빛사논문
- 조회617
J. Med. Virol., Nov 2023, 95 (11) | https://doi.org/10.1002/jmv.29228
Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study
Sung-Woon Kang 1, Jun-Won Kim 2, Ji Yeun Kim 1, So Yun Lim 1, Choi-Young Jang 1, Euijin Chang 1, Jeong-Sun Yang 2, Kyung-Chang Kim 2, Hee-Chang Jang 2, Dasol Kim 2, Younmin Shin 2, Joo-Yeon Lee 2, Sung-Han Kim 1
1Department of Infectious Diseases, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
2Center for Emerging Virus Research, National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheongju, Republic of Korea.
Sung-Woon Kang, Jun-Won Kim, and Ji Yeun Kim contributed equally to this study.
CORRESPONDING AUTHORS : Joo-Yeon Lee, Sung-Han Kim
Abstract
There are limited data supporting current Centers for Disease Control and Prevention guidelines for the isolation period in moderate to severely immunocompromised patients with coronavirus disease 2019 (COVID-19). Adult COVID-19 patients who underwent solid organ transplantation (SOT) or received active chemotherapy against hematologic malignancy were enrolled and weekly respiratory samples were collected. Samples with positive genomic real-time polymerase chain reaction results underwent virus culture and rapid antigen testing (RAT). A total of 65 patients (40 with hematologic malignancy and 25 SOT) were enrolled. The median duration of viable virus shedding was 4 weeks (interquartile range: 3-7). Multivariable analysis revealed that B-cell depletion (hazard ratio [HR]: 4.76) was associated with prolonged viral shedding, and COVID-19 vaccination (≥3 doses) was negatively associated with prolonged viral shedding (HR: 0.22). The sensitivity, specificity, positive predictive value, and negative predictive value of RAT for viable virus shedding were 79%, 76%, 74%, and 81%, respectively. The negative predictive value of RAT was only 48% (95% confidence interval [CI]: 33-65) in the samples from those with symptom onset ≤20 days, but it was as high as 92% (95% CI: 85-96) in the samples from those with symptom onset >20 days. About half of immunocompromised COVID-19 patients shed viable virus for ≥4 weeks from the diagnosis, and virus shedding was prolonged especially in unvaccinated patients with B-cell-depleting therapy treatment. RAT beyond 20 days in immunocompromised patients had a relatively high negative predictive value for viable virus shedding.
논문정보
- Research article
- 2023년 11월 (BRIC 등록일 2023-11-28)
- 국내 연구진
- 의약학 > 감염의학
댓글 작성 로그인
팝업 닫기관련 링크
관련분야 연구자보기
관련분야 논문보기
